Question 1

What specific benefits could my child expect from using the Liposorber® LA-15 System?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children clinical trial (NCT02235857). Contact the study team or your healthcare provider for specific answers.

Question 2

Are there any risks or side effects associated with this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children clinical trial (NCT02235857). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for my child's condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children clinical trial (NCT02235857). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like, and how often will we need to come for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children clinical trial (NCT02235857). Contact the study team or your healthcare provider for specific answers.

Question 5

Will my child need to stop any current medications before starting this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children clinical trial (NCT02235857). Contact the study team or your healthcare provider for specific answers.

Question 6

What support will be available for us during the treatment process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children clinical trial (NCT02235857). Contact the study team or your healthcare provider for specific answers.

What this study is about